PT97277A - Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante - Google Patents

Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante

Info

Publication number
PT97277A
PT97277A PT97277A PT9727791A PT97277A PT 97277 A PT97277 A PT 97277A PT 97277 A PT97277 A PT 97277A PT 9727791 A PT9727791 A PT 9727791A PT 97277 A PT97277 A PT 97277A
Authority
PT
Portugal
Prior art keywords
cyclosporin
xenoenxerto
aloenxerto
concording
collateral
Prior art date
Application number
PT97277A
Other languages
English (en)
Other versions
PT97277B (pt
Inventor
David James Graham White
Johan Beyers Van Den Bogaerde
Original Assignee
Imutran Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imutran Ltd filed Critical Imutran Ltd
Publication of PT97277A publication Critical patent/PT97277A/pt
Publication of PT97277B publication Critical patent/PT97277B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT97277A 1990-04-09 1991-04-08 Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante PT97277B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909007971A GB9007971D0 (en) 1990-04-09 1990-04-09 Pharmaceutical formulations

Publications (2)

Publication Number Publication Date
PT97277A true PT97277A (pt) 1992-01-31
PT97277B PT97277B (pt) 1998-08-31

Family

ID=10674123

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97277A PT97277B (pt) 1990-04-09 1991-04-08 Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante

Country Status (22)

Country Link
EP (1) EP0527762B1 (pt)
JP (1) JP3518547B2 (pt)
CN (1) CN1040178C (pt)
AT (1) ATE141167T1 (pt)
AU (1) AU7555591A (pt)
CZ (1) CZ283119B6 (pt)
DE (1) DE69121401T2 (pt)
DK (1) DK0527762T3 (pt)
ES (1) ES2090325T3 (pt)
GB (1) GB9007971D0 (pt)
GR (1) GR3021642T3 (pt)
HK (1) HK48597A (pt)
IE (1) IE911153A1 (pt)
IL (1) IL97788A (pt)
IN (1) IN173149B (pt)
MY (1) MY106158A (pt)
NZ (1) NZ237739A (pt)
PT (1) PT97277B (pt)
SG (1) SG47465A1 (pt)
SK (1) SK279949B6 (pt)
WO (1) WO1991015221A1 (pt)
ZA (1) ZA912467B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60020727T2 (de) 1999-10-27 2006-05-04 Robert London Zhong Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung
AU2001291579B2 (en) * 2000-09-29 2006-08-31 Viron Therapeutics Inc. Use of serp- 1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
EP2338511A3 (en) * 2004-05-14 2012-07-25 Alexion Pharmaceuticals, Inc. Prolongation of survival of an allograft by inhibiting complement activity
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
EP2073898A1 (en) 2006-10-10 2009-07-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Complement inhibition for improved nerve regeneration
CA2742802C (en) 2008-11-10 2019-11-26 Alexion Pharmaceuticals, Inc. Methods and compositions for treating complement-associated disorders
SI3011345T1 (sl) 2013-08-07 2017-12-29 Alexion Pharmaceuticals, Inc. Biomarkerski proteini za atipični hemolitični uremični sindrom (ahus)

Also Published As

Publication number Publication date
CN1056240A (zh) 1991-11-20
ES2090325T3 (es) 1996-10-16
HK48597A (en) 1997-04-25
PT97277B (pt) 1998-08-31
WO1991015221A1 (en) 1991-10-17
DE69121401D1 (de) 1996-09-19
CS9100988A2 (en) 1991-12-17
DK0527762T3 (da) 1996-09-02
AU7555591A (en) 1991-10-30
SK279949B6 (sk) 1999-06-11
IL97788A (en) 1998-02-08
DE69121401T2 (de) 1996-12-12
CZ283119B6 (cs) 1998-01-14
NZ237739A (en) 1993-09-27
ZA912467B (en) 1992-12-30
GB9007971D0 (en) 1990-06-06
IL97788A0 (en) 1992-06-21
JPH05507266A (ja) 1993-10-21
MY106158A (en) 1995-03-31
GR3021642T3 (en) 1997-02-28
IE911153A1 (en) 1991-10-09
SG47465A1 (en) 1998-04-17
EP0527762A1 (en) 1993-02-24
IN173149B (pt) 1994-02-19
CN1040178C (zh) 1998-10-14
JP3518547B2 (ja) 2004-04-12
ATE141167T1 (de) 1996-08-15
EP0527762B1 (en) 1996-08-14

Similar Documents

Publication Publication Date Title
IT8720689A0 (it) Procedimento e impianto per la separazione di sostanze leggere da miscele di substrati.
AR010385A1 (es) Compuesto derivado de propiofenona, proceso para su preparacion, composicion farmaceutica que lo contiene y uso de dicho compuesto.
MX173183B (es) Uso de la rapamicina para la preparacion de una composicion para inhibir el rechazo de transplantes de organos o tejidos en un mamifero que lo necesita
CO4700485A1 (es) Anticuerpos anti-icam-1 modificados y su uso en el tratamiento de inflamaciones
ES2186714T3 (es) Uso de sustipo simple alpha 8 en la preparacion de medicamentos para el tratamiento de infecciones virales del higado.
ES2016585B3 (es) Polibutilaminas y poliisobutilaminas, procedimiento para su preparacion y composiciones combustibles y lubricantes que contienen estas sustancias.
MX9101869A (es) Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas
BR8804098A (pt) Compostos,composicoes e processo para reducao da fitotoxidez de plantas de cultura
ES2063013T3 (es) Procedimiento para eliminar pirogenos.
ES2099158T3 (es) Tratamiento del rechazo de trasplantes o de enfermedades autoinmunitarias y complejo de la formula general x-pro-y-boropro asociada al mismo.
WO1995017899A3 (en) Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
DK0973735T3 (da) Polyaromatiske antivirale præparater
BR9306345A (pt) Métodos para suprimir a habilidade de células-t de um mamífero de proliferar e para suprimir resposta imune composições para uso na supressão da capacidade de células-t de proliferarem e na supressão de resposta imune
DK0408711T3 (da) S-adenosylmethionin til behandling af pancreatitis og immunafstødning ved pancreastransplantationer
PT97277A (pt) Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante
ES2065698T3 (es) Autobioticos y su utilizacion para eliminar in vivo celulas extrañas.
ES2063767T3 (es) Esteres aromaticos policiclicos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
ATE111118T1 (de) Flüssige sterilisierende zusammensetzung.
ES2048142T3 (es) Procedimiento de obtencion de polidesoxirribonucleotidos sustancialmente puros y no informacionales que tienen actividades biologicas, y producto respectivo.
NO884721L (no) Fremgangsmaate ved fremstilling av biologisk aktive komponenter.
MC1930A1 (fr) Produit antiviral
PT94685A (pt) Processo para a preparacao de 2-imidazolinas substituidas e de composicoes farmaceuticas que as contem
IT1213034B (it) Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
MX9800243A (es) Procedimiento para producir principios activos a partir de dispositivos no usados o descartados para la administracion transdermica de principios actios y/o a partir de desechos de fabricacion.
IT1237514B (it) Composti ad attivita' antitussiva, processo per la loro preparazione, loro composizioni farmaceutiche.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910911

FG3A Patent granted, date of granting

Effective date: 19980504

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20071105